SK bioscience operates a business Ethics and compliance management system based on the belief that a company’s competitiveness can only be proven when it secures a competitive advantage in the market while adhering to laws and regulations. In addition, we practice business ethics and compliance management by implementing our Prevent-Detect-Respond framework. This approach helps us avoid profits from unethical business practices and lays the foundation for a fairer and more transparent company.

We set business ethics regulations and regularly conduct annual business ethics and compliance training and pledges to prevent risks and embed ethical practices in our employees. Additionally, we operate a monitoring system that continuously checks marketing cost execution. We conduct business ethics practice surveys to evaluate the level of ethical practices, and the results are reflected to improve the business ethics and compliance management system.

We also operate a reporting channel where employees, business partners, customers, and all other stakeholders can freely consult and report unethical behavior of the Company and employees, and if violations are confirmed as the result of investigation and monitoring of reports, we follow disciplinary procedures, notify all employees, and reflect them in regulations and trainings.

we established audit compliance regulations and secured specialized audit personnel to ensure independent audits in 2022. Building on this foundation, we conducted regular audits focusing on cost and procurement areas in 2023, and further checked key expense items for potential misuse, reporting the results to the Audit Committee. We will continue to audit key areas of vulnerabilities to identify and remediate management leaks and inefficiencies.

SK bioscience has established a company-wide business and compliance management system and operates related programs. The Head of Legal & Patent Office is appointed as the Compliance Officer, responsible for planning, implementation, evaluation, and supervision of the entire process of the voluntary compliance program. In addition, the Business Ethics and Compliance Officer oversees business-related activities such as pharmaceutical compliance activities and programs to raise the level of awareness of voluntary fair trade compliance among all employees. The Compliance Officer reports annually to the Board on these activities and future plans.

We operate a dedicated compliance division (Ethics Management Team) to establish a compliance system, monitor and investigate reports. The Team also makes efforts to prevent compliance violations in advance by providing compliance-related training and imposing penalties for violations. In addition, in order to review the internal business system as the Company's business environment changes, we secured specialized audit personnel and added audit functions to the Ethics Management Team in 2022 to establish audit system. Since 2023, we have made every effort to upgrade the business ethics and compliance management system throughout the Company by conducting full-scale audit activities.

1. Board of Directors
2. 대표이사, 감사위원회
3. 법무특허실장(준법지원인/자율준수관리자)
4. 법무팀, 윤리경영팀

SK bioscience has appointed the head of the Legal & Patent Office as the Compliance Officer to practically carry out compliance control activities. The tenure for the Compliance Officer is three years, and he/she plays a key role in overseeing the Company's compliance works, strengthening the governance system and proactively preventing legal risks.

SK bioscience has strengthened its compliance system by specifying the activities, duties, and authority of the Compliance Officer in the Compliance Control Standards. The Compliance Officer is responsible for operating compliance education/training programs and checking whether the Guidelines are being followed. If necessary, the Compliance Officer may request employees to submit materials and seek advice from external experts, as well as make a statement to the Board in relation to compliance control. In addition to general compliance activities, the Compliance Officer strives to advance the company-wide compliance system through risk prevention activities, thereby contributing to the achievement of the Legal and Patent Office's 2030 long-term vision of becoming a “Proactive & Business-oriented Legal Solution Provider.

• 거버넌스 체계 정비

  이사회 중심 경영 정착

  이사회 프로세스 정착 및 산하 위원회 운영 지원

  관련 규제 〮 법령에 부합하는 운영체계 수립

  공시 의무, 자본시장법상 규제 준수, ESG 평가 대비

• 선제적 리스크 관리

  전사적/통합적 리스크 관리 체계 구축

  리스크 식별, 평가, 대응, 점검

  계약상 리스크 최소화

  분쟁 및 당사 리스크를 최소화하기 위한 계약 검토

• 국내외 사업 및 프로젝트 지원

  국내외 사업

  국내 마케팅 협약(Alliance) 규제 및 정책 모니터링, 대응

  프로젝트

  C(D)MO, 국내 유통 계약 시 당사의 책임 및 면책 범위 명확화

SK bioscience administers various forms of ethics training for all employees (including part-time) and contractors, to ensure comprehensive understanding and adherence to the Code of Ethics. SK Group's online ethical management training utilizes video contents based on various cases such as sincere execution of work, mutual respect, asset protection, conflicts of interest, and acceptance of money, valuables and entertainment to strengthen employees' ethical and compliance capabilities and internalize them into ethical decision-making. SK Group also conducts ethical management practice workshops at each organization where leaders and employees discuss ethical dilemmas and ways to practice business ethics together. Furthermore, the Company implements regular compliance training for the sales and marketing divisions and delivers ad-hoc training during the onboarding of new and experienced staff to fortify a robust internal compliance culture.

In order to raise employees' awareness of ethical practices, we first implemented company-wide ethical management self-education in 2023, and in 2024, we conducted self-education based on key ethical management issues for all employees.